Price (delayed)
$1.77
Market cap
$280.93M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.85
Enterprise value
$284.53M
enochian biosciences (formerly dandrit biotech usa inc.) a biopharmaceutical company, focuses on the development and commercialization of novel therapies aimed to change the course of immunotherapy treatments for hiv/aids and
There are no recent dividends present for RENB.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.